CPT code 84234: Progesterone receptor, tumor tissue analysis2026 Medicare lab fee · Clinical Laboratory Fee Schedule

Progesterone receptor analysis evaluates receptor status in tissue, commonly as part of pathology assessment of a breast tumor.

CMS CLFS 2026 Q4Effective Oct 1, 2026Same amount nationwide612 Medicare services in 2024

Medicare pays $64.88 for 84234 under the 2026 Clinical Laboratory Fee Schedule: one national amount, the same in every state and setting.

Medicare lab fee · CLFS 2026 Q4

National CLFS amount

$64.88

In effect since Jan 1, 2026. The same amount in every state, payment locality and setting.

Geographic adjustment
None
Office vs facility
Same
Since 2020
Unchanged
CMS updates
Quarterly

Medicare pays the lesser of the lab’s charge and this amount. Patients usually owe no Part B deductible or coinsurance for covered clinical lab tests.

On this page 8 sections
  1. Medicare lab fee
  2. What 84234 covers
  3. How it’s paid
  4. Amount history
  5. Similar tests
  6. Related codes
  7. Billing questions
  8. Sources

What 84234 covers

This test evaluates progesterone receptors in tissue rather than measuring progesterone circulating in blood. Pathology laboratories commonly report it as part of tumor characterization, especially in breast cancer assessment. The result describes the tumor’s progesterone receptor status and is distinct from a serum or plasma progesterone concentration test.

Report 84234 for progesterone receptor analysis; 84233 identifies a different receptor target. Medicare pays the test through the Clinical Laboratory Fee Schedule (CLFS), not the physician fee schedule. The 2026 national CLFS amount is $64.88 and has been unchanged since 2020. One amount applies nationwide, with no locality, geographic, office, or facility adjustment.

This summary was written with AI assistance from CMS Clinical Laboratory Fee Schedule data. Amounts on this page come directly from CMS files.

How Medicare pays 84234

Clinical lab tests aren’t priced like physician services. They’re paid from their own fee schedule, with its own rules. See the whole lab fee schedule.

One national amount

CMS sets a single Clinical Laboratory Fee Schedule amount for 84234. There’s no geographic (GPCI) adjustment, so it pays the same in every state and payment locality.

No office or facility rate

Lab tests aren’t built from relative value units, so there’s no office and facility split: the place of service doesn’t change the CLFS amount.

Updated every quarter

CMS republishes the CLFS each quarter. New tests, often proprietary laboratory analyses (PLA codes), join during the year; existing amounts are updated each January.

Excluded from the physician fee schedule

The physician fee schedule lists 84234 with status X (excluded by statute), so the test itself is paid only from the CLFS.

84234 on the lab fee schedule since 2020

84234 · CLFS 2026 Q4 (current)

$64.88

Unchanged since Jan 1, 2020

Amount in each year’s latest CLFS release · bars start at $0

27 quarterly CLFS releases on file, first CLFS 2020 Q1. A code missing from a quarter wasn’t on that release.

84234 compared with similar tests

84233Estrogen receptorTumor receptor analysis$87.88
Use 84233 for the other receptor target and 84234 for progesterone receptor analysis. The target documented by the laboratory distinguishes the codes.
84235Hormone receptor assayOther than estrogen or progesterone$71.23
84235 identifies an endocrine hormone assay; 84234 identifies progesterone receptor analysis.
84238Receptor assaySpecified nonendocrine receptor$36.57
84238 is for a nonendocrine receptor assay; 84234 is specifically for progesterone receptor analysis.
84144Progesterone testSerum concentration$20.86
84144 measures progesterone concentration, while 84234 evaluates progesterone receptors in tissue. Select according to the analyte and test performed.

84234 billing questions

Is 84234 a blood progesterone test?

No. It represents progesterone receptor analysis in tissue. A test measuring circulating progesterone is a different service.

How does 84234 differ from 84233?

84234 identifies progesterone receptor analysis, while 84233 identifies a different receptor target. Match the code to the target tested.

Can both 84234 and 84233 be reported?

They identify different receptor targets. The documented tests determine which code or codes describe the services performed.

Does Medicare pay 84234 under the physician fee schedule?

No. Medicare pays this test through the CLFS; it is excluded from the physician fee schedule.

Does the CLFS payment vary by location or setting?

No. One national CLFS amount applies across states and localities, without an office or facility difference.

Where this amount comes from

FeeBase reads lab amounts directly from the CMS Clinical Laboratory Fee Schedule file for the quarter: one row per code, with its payment indicator and national amount. Contractor-priced tests are labeled, never given a made-up amount. Amounts are Medicare payment limits, not a patient’s bill or a commercial rate.

CMS CLFS 2026 Q4 · effective Oct 1, 2026 through the day before Jan 1, 2027

Show the CMS file line behind this amount
CLFS row for 84234PUF_CLFS_CY2026_Q4V1.csv, line 1,438 (CLFS 2026 Q4)

Open CMS sourceHow we source rates

Did this answer your question about what Medicare pays for 84234?

Tell us what you were actually trying to work out. We’ll answer you directly, or build the page that does.

Fee sheets · Coming soon

Put 84234 and the rest of your codes on one sheet

Your codes at your locality, with payer contracts beside Medicare.

Join the waitlist